Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Fludalanine failed as an effective oral antibiotic despite efforts.

Thallium is highly toxic, causing severe health issues, and Prussian blue is the best antidote.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

Accurate diagnosis of APL is crucial to avoid unnecessary treatments.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

A three-year-old girl has hair loss despite treatment with selenium sulfide shampoo and anti-fungal medication.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Systemic cyproterone acetate and 5% topical minoxidil are effective and safe for treating female pattern hair loss.

Valproic acid is an effective and safe first-choice treatment for many types of seizures.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Stopping valproate and using lactulose can quickly treat valproate-induced hyperammonemia.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

Midazolam's antiseizure effects are mainly due to synaptic GABA-A receptors, not neurosteroids or extrasynaptic receptors.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.